SANA FY 2021 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$357M

Net Income

-$356M

EPS (Diluted)

$-2.14

Cash Flow

Operating Cash Flow

-$251M

Free Cash Flow

-$281M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$401M

Stockholders' Equity

$729M

Cash & Equivalents

$253M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$10M	+100.0%
Operating Income	-$357M	-$161M	-121.5%
Net Income	-$356M	-$285M	-24.8%